Impact of Covid-19 pandemic

RNS Number : 1316J
RiverFort Global Opportunities PLC
08 April 2020
 

8 April 2020

RiverFort Global Opportunities plc

("RGO" or the "Company")

Impact of Covid-19 pandemic

RGO wishes to provide shareholders and investors with an update on the impact of Covid-19 on the Company.

RGO has a strong balance sheet and is well-funded with a current cash balance of around £2.8 million.  Furthermore, RGO's investment portfolio principally comprises debt and equity-linked debt investments so the portfolio is currently unaffected by share price volatility.

Against the background of a difficult fund raising market, the Company is seeing an increasing number of new and attractive investment and funding opportunities through its investment adviser, RiverFort Global Capital Limited.  The Company is therefore actively working on deploying its investment capital to help provide companies with an alternative source of funding during this difficult period.

Phillip Haydn-Slater, Non-executive Chairman commented:

"I am pleased to say that RGO plc is in very good shape despite the current difficult set of circumstances that we are all dealing with.  The Company has significant funds available to deploy and is therefore continuing to look for and invest in new opportunities despite the current market turmoil."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For more information please contact:

RiverFort Global Opportunities plc


+44 20 3368 8978

Phillip Haydn-Slater, Non-executive Chairman






Nominated Adviser


+44 20 7628 3396

Beaumont Cornish



Roland Cornish/Felicity Geidt






Joint Broker


+44 20 7186 9950

Shard Capital Partners LLP



Damon Heath/ Erik Woolgar






Joint Broker


+44 20 7562 3351

Peterhouse Capital Limited



Lucy Williams



 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKZGGDRNFGGZM
UK 100

Latest directors dealings